The World Health Organization announced on Monday that it will start a new project to accelerate the development in poorer countries of vaccines for human bird flu infections using cutting-edge messenger RNA technology. The WHO said that Argentinian manufacturer Sinergium Biotech would lead the vaccine effort and had already begun developing candidate H5N1 vaccines.
Sinergium is aiming to establish proof-of-concept in preclinical models for its candidate vaccines, the WHO said.
Finland has already decided that it is going to offer the bird flu “vaccine” to people who are regularly exposed to poultry.
Finland Will Offer Bird Flu “Vaccine” To Some People
The United States has also already made a deal with Moderna to create a lot of “vaccines” for the bird flu.
U.S. Ruling Class Is Close To A “Deal” To Fund Moderna’s Bird Flu “Vaccine” Trial
The mainstream media is already crafting the official narrative as a “thank you” to the COVID control system put in place (for safety, of course) in the event that another plandemic surfaces. How convenient that there’s already a “vaccine” being developed and tested for the bird flu.
Swiftly developed mRNA COVID vaccines were game-changers during the pandemic, but they also exposed glaring global vaccine inequity and demands for a fairer distribution amid efforts to use the technology against other diseases. “This initiative exemplifies why WHO established the mRNA Technology Transfer Program,” the agency’s chief Tedros Adhanom Ghebreyesus said in a statement.
According to a report by The Medical Express, the bird flu H5N1 first emerged in 1996, but since 2020 an exponential growth in outbreaks in birds has occurred in parallel with the virus increasingly jumping to mammals, including cattle in US farms and a few humans.
The outbreak has been spreading to humans from cattle and could make the jumper from domestic cats.
The remainder of this article is available in its entirety at SHTF Plan